Chemours Co CC
The Chemours Company (herein referred to as "we", "us", or "our") is a leading, global provider of performance chemicals that are key inputs in end-products and processes in a variety of industries. We deliver customized solutions with a wide range of industrial and specialty chemical products for markets, including refrigeration and air conditioning, paints and coatings, plastics, transportation, semiconductor and consumer electronics, general industrial, and oil and gas. Our principal products include refrigerants, titanium dioxide ("TiO2") pigment and industrial fluoropolymer resins. We manage and report our operating results through three principal reportable segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. Our Thermal & Specialized Solutions segment is a leading, global provider of refrigerants, thermal management solutions, propellants, blowing agents, and specialty solvents. Our Titanium Technologies segment is a leading, global provider of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, and protection in a variety of applications. Our Advanced Performance Materials segment is a leading, global provider of high-end polymers and advanced materials that deliver unique attributes, including low friction coefficients, extreme temperature resistance, weather resistance, ultraviolet and chemical resistance, and electrical insulation.
Valuation FY2025 figures against the last close
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.81B | $5.78B | $6.08B | $6.83B | $6.34B | $4.97B | $5.53B | $6.64B | $6.18B | $5.40B |
| Cost of revenue | $4.91B | $4.64B | $4.78B | $5.21B | $4.96B | $3.90B | $4.46B | $4.67B | $4.44B | $4.30B |
| Gross profit | $902.0M | $1.14B | $1.30B | $1.62B | $1.38B | $1.07B | $1.06B | $1.97B | $1.75B | $1.10B |
| R&D | $108.0M | $109.0M | $108.0M | $118.0M | $107.0M | $93.0M | $80.0M | $82.0M | $81.0M | $81.0M |
| SG&A | $799.0M | $598.0M | $1.29B | $710.0M | $592.0M | $527.0M | $548.0M | $657.0M | $626.0M | $946.0M |
| Total operating expenses | $966.0M | $823.0M | $1.55B | $844.0M | $705.0M | $700.0M | $715.0M | $788.0M | $764.0M | $1.20B |
| Interest expense | $269.0M | $263.0M | $208.0M | $163.0M | $185.0M | $210.0M | $208.0M | $195.0M | $214.0M | $219.0M |
| Pre-tax income | -$277.0M | $106.0M | -$318.0M | $741.0M | $676.0M | $179.0M | -$124.0M | $1.16B | $912.0M | -$11.0M |
| Income tax | $109.0M | $37.0M | $66.0M | $163.0M | $68.0M | $40.0M | $72.0M | $159.0M | $165.0M | $18.0M |
| Net income | -$386.0M | $69.0M | -$253.0M | $578.0M | $608.0M | $219.0M | -$52.0M | $995.0M | $746.0M | $7.0M |
| EPS, basic | -2.57 | 0.46 | -1.70 | 3.72 | 3.69 | 1.33 | -0.32 | 5.62 | 4.04 | 0.04 |
| EPS, diluted | -2.57 | 0.46 | -1.70 | 3.65 | 3.60 | 1.32 | -0.32 | 5.45 | 3.91 | 0.04 |
| Shares, diluted (wtd. avg.) | $150.2M | $150.2M | $148.9M | $158.3M | $168.7M | $166.3M | $164.8M | $182.6M | $191.0M | $183.4M |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $670.0M | $713.0M | $1.20B | $1.30B | $1.55B | $1.10B | $943.0M | $1.20B | $1.56B | $902.0M |
| Receivables | $562.0M | $619.0M | $622.0M | $509.0M | $644.0M | $449.0M | $602.0M | $790.0M | $847.0M | $742.0M |
| Inventory | $1.57B | $1.46B | $1.35B | $1.40B | $1.10B | $939.0M | $1.08B | $1.15B | $935.0M | $767.0M |
| Total current assets | $3.00B | $3.02B | $3.84B | $3.21B | $3.35B | $2.63B | $2.78B | $3.29B | $3.49B | $2.55B |
| Property, plant and equipment | $3.13B | $3.19B | $3.21B | $3.17B | $3.15B | $3.47B | $3.56B | $3.29B | $3.01B | $2.78B |
| Goodwill | $46.0M | $46.0M | $102.0M | $102.0M | $102.0M | $153.0M | $153.0M | — | $153.0M | $153.0M |
| Other intangibles | $2.0M | $3.0M | $3.0M | $13.0M | $6.0M | $14.0M | $21.0M | $28.0M | $13.0M | $17.0M |
| Total assets | $7.46B | $7.51B | $8.24B | $7.64B | $7.55B | $7.08B | $7.26B | $7.36B | $7.29B | $6.06B |
| Accounts payable | $954.0M | $1.16B | $1.16B | $1.23B | $1.16B | $844.0M | $923.0M | $1.14B | $1.07B | $884.0M |
| Short-term debt | $42.0M | $54.0M | $51.0M | $43.0M | $25.0M | $21.0M | $134.0M | $13.0M | $15.0M | $15.0M |
| Total current liabilities | $1.83B | $1.82B | $2.49B | $1.89B | $1.86B | $1.44B | $1.54B | $1.71B | $1.65B | $1.77B |
| Long-term debt | $4.11B | $4.06B | $3.99B | $3.59B | $3.72B | $4.00B | $4.03B | $3.96B | $4.10B | $3.53B |
| Total liabilities | $7.23B | $6.94B | $7.52B | $6.53B | $6.47B | $6.27B | $6.56B | $6.34B | $6.43B | $5.96B |
| Retained earnings | $1.25B | $1.69B | $1.78B | $2.17B | $1.75B | $1.30B | $1.25B | $1.47B | $579.0M | -$114.0M |
| Total equity | $228.0M | $571.0M | $721.0M | $1.11B | $1.08B | $815.0M | $695.0M | $1.02B | $865.0M | $104.0M |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $264.0M | -$633.0M | $556.0M | $755.0M | $814.0M | $807.0M | $650.0M | $1.14B | $640.0M | $594.0M |
| Depreciation and amortisation | $340.0M | $292.0M | $309.0M | $291.0M | $317.0M | $320.0M | $311.0M | $284.0M | $273.0M | $284.0M |
| Stock-based compensation | $21.0M | $15.0M | $18.0M | $27.0M | $34.0M | $16.0M | $19.0M | $24.0M | $29.0M | — |
| Capital expenditure | $213.0M | $360.0M | $370.0M | $307.0M | $277.0M | $267.0M | $481.0M | $498.0M | $411.0M | $338.0M |
| Investing cash flow | -$206.0M | -$353.0M | -$229.0M | -$284.0M | $220.0M | -$234.0M | -$483.0M | -$487.0M | -$370.0M | $357.0M |
| Financing cash flow | -$126.0M | -$36.0M | $172.0M | -$686.0M | -$554.0M | -$449.0M | -$419.0M | -$993.0M | $352.0M | -$396.0M |
| Dividends paid | $78.0M | $148.0M | $149.0M | $154.0M | $164.0M | $164.0M | $164.0M | $148.0M | $22.0M | $22.0M |
| Buybacks | — | — | $69.0M | $495.0M | $173.0M | $0 | $322.0M | $644.0M | $106.0M | $0 |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001193125-26-065201.
Others in SIC 2800
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| SOLS | Solstice Advanced Materials Inc. | $10.12B | 42.8x | 3.1% |
| PRM | Perimeter Solutions, Inc. | $5.20B | — | 16.4% |
| NGVT | Ingevity Corp | $2.43B | — | -2.7% |
| IOSP | INNOSPEC INC. | $2.31B | 20.1x | -3.7% |
| OLN | OLIN Corp | $1.98B | — | 3.7% |
| HUN | Huntsman CORP | $1.69B | — | -5.8% |
| FMC | FMC CORP | $1.62B | — | -18.3% |
| ECVT | Ecovyst Inc. | $1.12B | — | 20.9% |